{
    "title": "FDA staff flags uncertainties on Veru's COVID drug; EUA hopes lift shares",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11399137/FDA-staff-flags-uncertainties-Verus-COVID-19-drug.html",
    "date": "2022-11-07",
    "keywords": [
        "drug",
        "fda",
        "trial",
        "bhanvi",
        "satija",
        "authorization",
        "death",
        "analyst",
        "committee",
        "eua",
        "study",
        "veru",
        "sabizabulin",
        "treatment",
        "staff",
        "food",
        "administration",
        "incs",
        "argument",
        "emergency",
        "use",
        "size",
        "patient",
        "population",
        "rate",
        "placebo",
        "group",
        "none",
        "mortality",
        "benefit",
        "panel",
        "health",
        "week",
        "cantor",
        "brandon",
        "posteua",
        "risk",
        "acute",
        "respiratory",
        "distress",
        "application",
        "latestage",
        "reduction",
        "uncertainty",
        "bit",
        "relief",
        "leland",
        "gershell",
        "verus",
        "afternoon",
        "trading",
        "midseptember",
        "meeting",
        "prostate",
        "cancer",
        "market",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}